The RCC International Metastatic Database Consortium (IDMC) Risk Score defines adverse clinical prognostic risk factors in patients with ccRCC treated with VEGF-targeted therapy [21, 22]. Here, VEGFA is linked to nonpapillary renal cell carcinoma.